Inogen (INGN) Times Interest Earned (2013 - 2022)
Inogen (INGN) reported Times Interest Earned of -$857.67 for Q3 2022, down 6370.36% year-over-year from $13.68 in Q3 2021, and down 6370.36% on a QoQ basis from $13.68 in Q3 2021.
Inogen (INGN) has 6 years of Times Interest Earned data on file, last reported at -$857.67 in Q3 2022.
- Quarterly Times Interest Earned fell 6370.36% year-over-year to -$857.67 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was -$8538.7 (down 23639.75% YoY) and the FY2016 annual result came in at $3810.7, up 457.0% from the prior year.
- Times Interest Earned fell to -$857.67 in Q3 2022 per INGN's latest filing, from $13.68 in the prior quarter.
- Across five years, Times Interest Earned topped out at $13.68 in Q3 2021 and bottomed at -$857.67 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.98 |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -857.67 |
| Sep 30, 2021 | 13.68 |
| Sep 30, 2016 | 5,397.00 |
| Jun 30, 2016 | 4,009.50 |
| Mar 31, 2016 | 1,092.33 |
| Dec 31, 2015 | 868.50 |
| Sep 30, 2015 | 742.80 |
| Jun 30, 2015 | 890.83 |
| Mar 31, 2015 | 359.71 |
| Dec 31, 2014 | 159.11 |
| Sep 30, 2014 | 34.30 |
| Jun 30, 2014 | 19.52 |
| Mar 31, 2014 | 11.65 |
| Dec 31, 2013 | 2.21 |
| Sep 30, 2013 | 7.84 |
| Jun 30, 2013 | 25.18 |
| Mar 31, 2013 | 6.09 |